[Skip to Content]
[Skip to Content Landing]

September 2019 - January 1929

Decade

Year

Issue

May 2015, Vol 133, No. 5, Pages 501-621

In This Issue of JAMA Ophthalmology

Highlights

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):501. doi:10.1001/jamaophthalmol.2014.3717
Original Investigation

Journal Club

Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):503-510. doi:10.1001/jamaophthalmol.2014.5108

This cohort study reports weak or absent associations between serum lipid levels and incident proliferative diabetic retinopathy and macular edema in patients with long-standing type 1 diabetes.

Founder Effect of a c.828+3A>T Splice Site Mutation in Peripherin 2 (PRPH2) Causing Autosomal Dominant Retinal Dystrophies

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):511-517. doi:10.1001/jamaophthalmol.2014.6115

This study reports the PRPH2 c.828+3A>T splice site mutation is a frequent cause of inherited retinal dystrophies owing to the founder effect and that the likely cause of disease is the missplicing of the PRPH2 message that results in a truncated protein product.

Clinical Trial

Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):518-525. doi:10.1001/jamaophthalmol.2015.1

Outcomes of an Inner-City Vision Outreach Program: Give Kids Sight Day

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):527-532. doi:10.1001/jamaophthalmol.2015.8

This retrospective case-series study describes the outcomes of Give Kids Sight Day, an outreach ophthalmic care program held annually in Philadelphia, Pennsylvania, providing vision screening and immediate treatment when needed.

Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):533-541. doi:10.1001/jamaophthalmol.2015.18

This retrospective cohort study finds that genetic and environmental risk factors influence the age at onset of neovascular age-related macular degeneration.

Extended Follow-up of Treated and Untreated Retinopathy in Incontinentia Pigmenti: Analysis of Peripheral Vascular Changes and Incidence of Retinal Detachment

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):542-548. doi:10.1001/jamaophthalmol.2015.22

This observational cohort study finds that eyes with retinopathy due to incontinentia pigmenti should be monitored during infancy, early childhood, and throughout adulthood for the development of retinal complications.

Determination of Bleb Capsule Porosity With an Experimental Glaucoma Drainage Device and Measurement System

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):549-554. doi:10.1001/jamaophthalmol.2015.30

This experimental interventional study finds that a new glaucoma drainage device has porosity similar to that of an existing device as well as similar histologic properties.

Strabismus Surgical Subspecialization: A Population-Based Analysis

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):555-559. doi:10.1001/jamaophthalmol.2015.38

This population-based study shows that strabismus surgery has evolved into a subspecialized field of ophthalmology during the past 15 years.

Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):560-567. doi:10.1001/jamaophthalmol.2015.44

This Markov cohort model study found trabeculectomy to be more cost-effective than tube insertion.

Journal Club

Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):568-573. doi:10.1001/jamaophthalmol.2015.51

This prospective, multicenter randomized clinical trial found that patients receiving fluocinolone acetonide implants are at higher risk of increased intraocular pressure.

Trabeculectomy-Related Complications in Olmsted County, Minnesota, 1985 Through 2010

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):574-580. doi:10.1001/jamaophthalmol.2015.57

In this retrospective, population-based study, the incidence of vision-threatening complications after trabeculectomy during 20 years was comparable to those of shorter studies.

Reticular Pseudodrusen Associated With a Diseased Bruch Membrane in Pseudoxanthoma Elasticum

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):581-588. doi:10.1001/jamaophthalmol.2015.117

This single-center, prospective, cross-sectional case series found that diseased Bruch membrane in pseudoxanthoma elasticum suggests a pathogenetic role of Bruch membrane alterations for the development of reticular pseudodrusen.

Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):589-597. doi:10.1001/jamaophthalmol.2015.186

This exploratory analysis found that, in eyes with center-involved diabetic macular edema and no prior open-angle glaucoma, repeated intravitreous injections of ranibizumab may increase the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.

Invited Commentary

Telemedicine and Eye Examinations for Diabetic Retinopathy: A Time to Maximize Real-World Outcomes

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):525-526. doi:10.1001/jamaophthalmol.2015.0333
Special Communication

Genetic Testing for Age-Related Macular Degeneration: Not Indicated Now

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):598-600. doi:10.1001/jamaophthalmol.2015.0369

This Special Communication reports that improved outcomes for genotyped patients have not yet been demonstrated in a prospective clinical trial, and as a result, the costs and risks of routine genetic testing currently outweigh the benefits for patients with age-related macular degeneration.

JAMA Ophthalmology Clinical Challenge

New Pigmented Lesion Over a Site of Tumor Treatment

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):601-602. doi:10.1001/jamaophthalmol.2014.6122

Chloroquine Retinopathy

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):603-604. doi:10.1001/jamaophthalmol.2014.6127
Research Letter

Use of Laboratory Markers in Deciding Whether to Perform Temporal Artery Biopsy

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):605-606. doi:10.1001/jamaophthalmol.2014.5861

Time Course and Predictors of Amblyopia Improvement With 2 Hours of Daily Patching

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):606-609. doi:10.1001/jamaophthalmol.2015.6

Clinicopathological Correlation of Outer Retinal Tubulation in Age-Related Macular Degeneration

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):609-612. doi:10.1001/jamaophthalmol.2015.126
Observation

Presumed Primary Papillary Sebaceous Carcinoma of the Palpebral Conjunctiva

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):612-614. doi:10.1001/jamaophthalmol.2014.5870

Paracentral Acute Middle Maculopathy in Sickle Cell Disease

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):614-616. doi:10.1001/jamaophthalmol.2014.6098

Endogenous Endophthalmitis With Iris Abscess After Routine Dental Cleaning

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):616-617. doi:10.1001/jamaophthalmol.2015.12
Comment & Response

Potential Effect of the Presence of Gray Crescent on Analysis of Optic Disc and Retinal Nerve Fiber Layer Defects

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):617-618. doi:10.1001/jamaophthalmol.2014.5329

Potential Effect of the Presence of Gray Crescent on Analysis of Optic Disc and Retinal Nerve Fiber Layer Defects—Reply

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):618. doi:10.1001/jamaophthalmol.2014.5331

Representation of Disease: What’s in a Name?

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):618-619. doi:10.1001/jamaophthalmol.2014.5655

Atropine vs Patching

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):619. doi:10.1001/jamaophthalmol.2014.6111

Atropine vs Patching—Reply

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):619-620. doi:10.1001/jamaophthalmol.2014.6131

Women in Print

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):620-621. doi:10.1001/jamaophthalmol.2015.221

Women in Print—Reply

Abstract Full Text
JAMA Ophthalmol. 2015;133(5):621. doi:10.1001/jamaophthalmol.2015.223
Correction

Incorrect Data in Abstract and Table

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):621. doi:10.1001/jamaophthalmol.2015.0853

Omission in Article Information

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):621. doi:10.1001/jamaophthalmol.2015.1176

Error in Byline

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):621. doi:10.1001/jamaophthalmol.2015.1387
JAMA Ophthalmology Masthead

JAMA Ophthalmology

Abstract Full Text
free access
JAMA Ophthalmol. 2015;133(5):502. doi:10.1001/jamaophthalmol.2014.3718
×